The Ovarian Cancer Research Foundation’s primary focus is to fund ovarian cancer research. Research remains the only solution to save women’s lives.
Across the ovarian cancer research sector, there are four key research priorities agreed by researchers, clinicians and consumers. These four priorities are upheld by the OCRF and are a critical driver of our research strategy.
The four ovarian cancer research priorities are:
Improving treatment options to increase survival rates.
Saving lives through early diagnosis.
Reducing disease prevalence through preventative research.
Better management of recurrent disease to enhance survival and quality of life.
The OCRF exists to save lives through funding research. Our strategy is informed by those at the forefront of the disease and is based on the key research impacts of improving survival and decreasing the threat of ovarian cancer.

Our research strategy is underpinned by the research priorities that guide our funding process, ensuring the most innovative ovarian cancer research around Australia can receive OCRF funding.
In the State of the Nation in Ovarian Cancer Research Audit we consulted consumers, clinicians and researchers to inform our three goals for the future of ovarian cancer. These goals are central to our vision of a world where every woman, everywhere, is free from the threat of ovarian cancer.
To improve survival rates to 50 per cent for women today by rapidly incorporating recent research advances into clinical practice nationally.
To improve 5-year survival rates beyond 50 per cent for the next generation of women through development of testing and increased access to innovative personalised treatments.
To improve 5-year survival rates towards 90 per cent through development of early detection and diagnosis.
At the foundation of all of the OCRF’s activities are four guiding principles that ensure the broader ovarian cancer research sector can benefit from shared learnings and collaboration as we work towards a future free from the threat of ovarian cancer, together. Breakthroughs take a team.
The most lethal ovarian cancer subtypes that pose the greatest threat.
Long-term research funding to attract and retain the best and brightest to the ovarian cancer research field.
Connecting funding, resources, expertise, data and biospecimens to promote research success.
Better management of recurrent disease to enhance survival and quality of life.
You can help the OCRF provide sustainable, reliable funding to the game-changers in the ovarian cancer research community. Learn more about how our community is backing the best and brightest minds around Australia.